Literature DB >> 17431655

Endolaryngeal cordectomy using cold instruments for treatment of T1 glottic cancers.

Fikret Kasapoglu1, Levent Erisen, Hakan Coskun, Oğuz Basut.   

Abstract

In the treatment of early-stage glottic cancers, radiotherapy and surgery have similar success rates. In our department, we have been using cold instruments coupled with surgical microscope and/or telescopes for several years in treatment of early stage glottic cancers. Our aims were, to present our experience with endolaryngeal resection of T1 glottic cancers with cold instruments coupled with surgical microscope and telescopes, to present our oncological results, to discuss the advantages of endolaryngeal cordectomy over open cordectomy or RT and to discuss whether laser is obligatory for this approach or not. Our study includes retrospective analysis of 38 patients with T1 glottic cancer, who have been treated with endolaryngeal surgery as the primary treatment. The median follow-up was 24 months. The most commonly performed procedure was type-II cordectomy (38.5%). Overall survival rate was 94.7%, while the disease-specific survival rate was 100%. Local recurrences occurred in two patients at 8th and 11th months, postoperatively. In the first patient, type-Vc cordectomy and in the second type-Va cordectomy had been performed. Both patients with recurrences could be salvaged by fronto-lateral laryngectomy, and are still alive in their 38th and 6th months following salvage surgery. Therefore, the local control rate and larynx preservation rate with endolaryngeal cordectomy were 94.7 and 100%, respectively, in this study group. All patients had a voice quality sufficient for communicating easily over telephone. We believe that lasers are not obligatory to perform endolaryngeal cordectomy for treatment of T1 glottic cancers, as the same oncological and similar functional outcomes may be achieved with the traditional cold instruments.

Entities:  

Mesh:

Year:  2007        PMID: 17431655     DOI: 10.1007/s00405-007-0307-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  32 in total

1.  Laser surgery for vocal cord carcinoma involving the anterior commissure.

Authors:  Y P Krespi; C J Meltzer
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-02       Impact factor: 1.547

2.  Local recurrences following transoral laser surgery for early glottic carcinoma: frequency, management, and outcome.

Authors:  H E Eckel
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-01       Impact factor: 1.547

3.  Voice results in patients with T1a glottic cancer treated by radiotherapy or endoscopic measures.

Authors:  J Wedman; J-H Heimdal; I Elstad; Jan Olofsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2002-07-05       Impact factor: 2.503

Review 4.  Primary treatment of the anterior vocal commissure squamous carcinoma.

Authors:  Patrick J Bradley; Alessandra Rinaldo; Carlos Suárez; Ashok R Shaha; C René Leemans; Johannes A Langendijk; Snehal G Patel; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-15       Impact factor: 2.503

5.  Electrosurgical endoscopic cordectomy with microdissection electrodes: a comparative study with CO2 laser.

Authors:  J Basterra; E Zapater; R Moreno; R Hernández
Journal:  J Laryngol Otol       Date:  2006-05-24       Impact factor: 1.469

6.  Microlaryngoscopic surgery for T1 glottic lesions: a cost-effective option.

Authors:  E N Myers; R L Wagner; J T Johnson
Journal:  Ann Otol Rhinol Laryngol       Date:  1994-01       Impact factor: 1.547

7.  Negative pathology following endoscopic resection of T1a squamous carcinoma of the glottis.

Authors:  R Nassif; S Loughran; C Moyes; K MacKenzie
Journal:  J Laryngol Otol       Date:  2005-08       Impact factor: 1.469

Review 8.  Management of T1-T2 glottic carcinomas.

Authors:  William M Mendenhall; John W Werning; Russell W Hinerman; Robert J Amdur; Douglas B Villaret
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

9.  Quality of life, functional outcome, and costs of early glottic cancer.

Authors:  Jonathan C Smith; Jonas T Johnson; David M Cognetti; Douglas P Landsittel; William E Gooding; Elmer R Cano; Eugene N Myers
Journal:  Laryngoscope       Date:  2003-01       Impact factor: 3.325

10.  Early glottic carcinoma: treatment according patient's preference?

Authors:  Sandro J Stoeckli; Isabel Schnieper; Pia Huguenin; Stephan Schmid
Journal:  Head Neck       Date:  2003-12       Impact factor: 3.147

View more
  2 in total

1.  Is There a Change in the Treatment of T1 Glottic Cancer After CO2 Laser? A Comparative Study with Cold Steel.

Authors:  Uygar Levent Demir; Turgut Çevik; Fikret Kasapoğlu
Journal:  Turk Arch Otorhinolaryngol       Date:  2018-06-01

2.  Analysis of Recurrence after Frontolateral Laryngectomy.

Authors:  Yılmaz Özkul; Düzgün Ateş; Abdulkadir İmre; Murat Songu; Koray Balcı; Feda Bayrak; Kazım Önal
Journal:  Turk Arch Otorhinolaryngol       Date:  2017-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.